Tarsus Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TARS Nasdaq 2834 tarsusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals (TARS) Stock Looks Reasonable On Sales While Earnings Stay Weak - Aug 13th, 2026 5:14 pm
Tarsus (TARS) Q2 2026 Earnings Call Transcript - Aug 13th, 2026 12:32 pm
Tarsus Pharmaceuticals Q2 Earnings Call Highlights - Aug 7th, 2026 11:04 am
Tarsus joins Stargardt race to market with $800m Alkeus takeover - Aug 7th, 2026 6:13 am
Tarsus Pharmaceuticals Inc (TARS) (Q2 2026) Earnings Call Highlights: Record XDEMVY Sales and ... - Aug 6th, 2026 1:02 pm
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - Aug 6th, 2026 8:07 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2026 6:20 am
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth - Aug 6th, 2026 5:03 am
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing - Aug 6th, 2026 5:02 am
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position - Aug 6th, 2026 5:01 am
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Aug 5th, 2026 6:02 pm
Agenus (AGEN) Earnings Expected to Grow: Should You Buy? - Jul 30th, 2026 8:00 am
Tarsus Pharmaceuticals, Inc. (TARS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Jul 29th, 2026 8:00 am
Tarsus Pharmaceuticals (TARS) Replaces Its Commercial Chief While iRenix Talks Continue - Jul 15th, 2026 8:11 pm
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth - Jul 13th, 2026 2:05 pm
Tarsus Pharmaceuticals Enters Retina Market With iRenix Deal, Adds IRX-101 to Pipeline - Jul 11th, 2026 8:02 am
ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership - Jul 10th, 2026 2:04 am
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101 - Jul 8th, 2026 2:05 pm
All You Need to Know About Tarsus Pharmaceuticals (TARS) Rating Upgrade to Buy - Jul 8th, 2026 10:00 am